Abstract:Human recombinant CD38 catalyzes the formation of both cyclic ADP-ribose and ADP-ribose products from NAD+ and hydrolyzes cyclic ADP-ribose to ADP-ribose. The corresponding GDP products are formed from NGD+. The enzyme was characterized by substrate and inhibition kinetics, exchange studies, rapid-quench reactions, and stopped-flow-fluorescence spectroscopy to establish the reaction mechanism and energetics for individual steps. Noncyclizable substrates NMN+ and nicotinamide-7-deaza-hypoxanthine dinucleotide (7-deaza NHD+) were rapidly hydrolyzed by the enzyme. The kcat for NMN+ was 5-fold higher than that of NAD+ and has the greatest reported kcat of any substrate for CD38. 7-deaza-NHD+ was hydrolyzed at approximately one-third the rate of NHD+ but does not form a cyclic product. These results establish that a cyclic intermediate is not required for substrate hydrolysis. The ratio of methanolysis to hydrolysis for cADPR and NAD+ catalyzed by CD38 increases linearly with MeOH concentration. Both reactions produce predominantly the beta-methoxy riboside compound, with a relative nucleophilicity of MeOH to H2O of 11. These results indicate the existence of a stabilized cationic intermediate for all observed chemistries in the active site of CD38. The partitioning of this intermediate between cyclization, hydrolysis, and nicotinamide-exchange unites the mechanisms of CD38 chemistries. Steady-state and pre-steady-state parameters for the partition and exchange mechanisms allowed full characterization of the reaction coordinate. Stopped-flow methods indicate a burst of cGDPR formation followed by the steady-state reaction rate. A lag phase, which was NGD+ concentration dependent, was also observed. The burst size indicates that the dimeric enzyme has a single catalytic site formed by two subunits. Pre-steady-state quench experiments did not detect covalent intermediates. Nicotinamide hydrolysis of NGD+ precedes cyclization and the chemical quench decomposes the enzyme-bound species to a mixture of cyclic and hydrolysis products. The time dependence of this ratio indicated that nicotinamide bond-breakage occurs 4 times faster than the conversion of the intermediate to products. Product release is the overall rate-limiting step for enzyme reaction with NGD+.

Covalent and Noncovalent Intermediates of an NAD Utilizing Enzyme, Human CD38

Structural Basis for the Mechanistic Understanding of Human CD38-controlled Multiple Catalysis.

Dynamic Conformations of the CD38-mediated NAD Cyclization Captured in a Single Crystal.

A Covalent Intermediate in CD38 is Responsible for ADP-Ribosylation and Cyclization Reactions

Catalysis-associated Conformational Changes Revealed by Human CD38 Complexed with a Non-Hydrolyzable Substrate Analog.

The Reaction Mechanism for CD38. A Single Intermediate is Responsible for Cyclization, Hydrolysis, and Base-Exchange Chemistries

Synthesis and Biological Evaluation of Nicotinamide Adenine Dinucleotides Analogues As Inhibitors of Cd38

Design, Synthesis and Biological Evaluation of Noncovalent Inhibitors of Human CD38 NADase

Mechanism of Cyclizing NAD to Cyclic ADP-ribose by ADP-ribosyl Cyclase and CD38

Design, Synthesis and Biological Characterization of Novel Inhibitors of CD38.

Acidic Residues at the Active Sites of CD38 and ADP-ribosyl Cyclase Determine Nicotinic Acid Adenine Dinucleotide Phosphate (NAADP) Synthesis and Hydrolysis Activities*

Structural Basis for Formation and Hydrolysis of the Calcium Messenger Cyclic ADP-ribose by Human CD38*

Structure and Enzymatic Functions of Human CD38.

The Synthesis of Purine Derivatives and Its Inhibitory Activity on CD38 NADase

A Single Residue at the Active Site of CD38 Determines Its NAD Cyclizing and Hydrolyzing Activities

Structural Basis for Enzymatic Evolution from a Dedicated ADP-ribosyl Cyclase to a Multifunctional NAD Hydrolase

Revealing CD38 Cellular Localization Using a Cell Permeable, Mechanism-Based Fluorescent Small-Molecule Probe

Structural Characterization of Enzymatic Interactions with Functional Nicotinamide Cofactor Biomimetics

Design, Synthesis And Sar Studies Of Nad Analogues As Potent Inhibitors Towards Cd38 Nadase

Catalysis-Based Inhibitors Of The Calcium Signaling Function Of Cd38

Interactions of SIRT1 with Acetyl Substrate, NAD+ or Nicotinamide